Name: Latest research reports of Divi's Laboratories Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Divi's Laboratories Ltd.
Rating: 3
Author: BOB Capital Markets Ltd.

Divi's Laboratories Ltd.

NSE: DIVISLAB | BSE: 532488 | ISIN: INE361B01024 | Industry: Pharmaceuticals
| Expensive Performer

6474.0000 78.50 (1.23%)

NSE Feb 26, 2026 15:31 PM

30.66% Gain from 52W Low

Volume: 392.4K

Divi's Laboratories Ltd.

06 Aug 2025

6474.00

1.23%

Divi's Labs (HOLD): Long-term supply agreements to offset macro headwinds

Hold: Divi's Laboratories Ltd.

Target

BOB Capital Markets Ltd.

Earnings below estimates, largely on price erosion pressure in generics offsetting the impact of Kakinada unit 3 on margins

Number of FII/FPI investors decreased from 897 to 868 in Dec 2025 qtr